Baxter suspends HemAssist in Europe
Article Abstract:
Baxter International Inc., based in Deerfield, IL, suspended a European trial of HemAssist, a blood substitute, following its conclusion that the product has no advantages over donated blood. The suspension leaves the company with a $110-million Swiss facility, which will have no product to produce. The company ended its clinical trial in the US after finding that more people died with the product compared to the group that received donated blood. HemAssist has long been targeted by the company as a potential blockbuster product and has invested around $500 million for its development.
Comment:
Suspends European trial of HemAssist, a blood substitute, following conclusion that product has no advantages over donated blood
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Glaxo to announce discovery of genes behind three diseases; breakthroughs in migraine, psoriasis, diabetes meant to shake up industry; Dr. Roses points the way
Article Abstract:
Glaxo Wellcome PLC plans to announce on Oct 19, 1999 that it has come close to identifying the genes that make people susceptible to migraines, psoriasis, and diabetes. Glaxo's co-director of exploratory science, Dr. Allen Roses will release information about the 3 genes before publishing the research in a peer-reviewed scientific journal, a decision which is expected to be controversial. Glaxo has not yet filed patents on the discoveries of the migraine, psoriasis, and diabetes genes, which were identified using single nucleotide polymorphism technology.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Ugly in the air: Boeing's new plane gets gawks, stares
Article Abstract:
Boeing Co. of the United States is developing a new offering, the Large Cargo Freighter. The cargo carrier is a standard 747 that has been overhauled and is considered an "ugly duckling." Upon completion of testing it will be repainted white with a blue tail.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic: